Grammidin baby tab. d / rassas. 1.5mg + 1mg # 18

Release form, composition and packaging

White or off-white lozenges, round, biconvex, beveled, with GR on one side and raspberry scent

slight marbling is allowed.

1 tab.

gramicidin C (in the form of dihydrochloride) 1.5 mg

cetylpyridinium chloride (in the form of monohydrate) 1 mg

colloidal silicon dioxide (aerosil 200) 5 mg, talc 60 mg, citric acid monohydrate 36 mg, aspartame 12 mg, raspberry flavor 3.6 mg, sorbitol (Neosorb) 1055.9 mg, magnesium stearate 25 mg.

6 pcs.

- contour cell packages (2) - cardboard packs.

6 pcs.

- contour cell packages (4) - cardboard packs.

9 pcs.

- contour cell packages (2) - cardboard packs.

pharmachologic effect

Combined drug for topical use.

Gramicidin C is an antimicrobial agent.

The mechanism of action is associated with an increase in the permeability of the cytoplasmic membrane of the microbial cell, which violates its stability and causes cell death.

Gramicidin C has a pronounced antimicrobial effect against causative agents of infectious diseases of the oral cavity and pharynx.

Cetylpyridinium chloride is an antiseptic.

Suppresses the growth and reproduction of pathogens of infectious diseases of the oral cavity.

The combined drug reduces inflammation, has an antimicrobial effect, softens discomfort in the throat, facilitates swallowing, and when absorbed, causes hypersalivation, which contributes to the mechanical cleansing of the oral cavity and pharynx from microorganisms.

Pharmacokinetics

Active substances have a local effect and are almost not absorbed from the gastrointestinal tract, which determines the almost complete absence of systemic effects.

Indications for use

Infectious and inflammatory diseases of the oral cavity and pharynx: angina

pharyngitis

tonsillitis

periodontal disease

gingivitis

stomatitis.

Contraindications for use

Children under 4 years old

I trimester of pregnancy

hypersensitivity to the components that make up the drug.

Dosage regimen

For resorption or treatment of the oral cavity.

Apply 1-4 times / day, depending on indications, patient's age and dosage form.

Immediately after use, you should refrain from eating and drinking for 1-2 hours.

Side effect

Perhaps: in some cases - allergic reactions.

Drug interactions

Strengthens the effects of other local and systemic antimicrobial agents.

Application during pregnancy and lactation

Use in the first trimester of pregnancy is contraindicated.

If necessary, use during lactation, breastfeeding should be discontinued at the time of admission.

Special instructions In the absence of a therapeutic effect within 7 days of use, you should consult a doctor.

Name ENG

GRAMMIDIN FOR CHILDREN

Clinical and pharmacological group

Antiseptic for topical use in ENT practice and dentistry

ATX code

Drugs for the treatment of diseases of the pharynx

Dosage

1.5mg + 1mg

Structure

1 tablet contains: active substance: gramicidin C1.5 mg (1500 units)

excipients: sugar, lactose, methylcellulose, calcium stearate.

Indications

Infectious and inflammatory diseases of the oral cavity and pharynx: angina

pharyngitis

tonsillitis

periodontal disease

gingivitis

stomatitis

Contraindications

Children under 4 years old

I trimester of pregnancy

hypersensitivity to the components that make up the drug

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 2 years

INN / Active ingredient

gramicidin C, cetylpyridinium chloride

Specifications

Category

Sore throat

Scope of the drug

Ear, Throat, Nose

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

eighteen

Minimum age from

4 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Valenta Pharmaceuticals

The amount of the dosage form in the primary package

9 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antibiotic + antiseptic

Anatomical and therapeutic characteristics

R02A Drugs for the treatment of throat disorders

Dosage form

Lozenges

The target audience

Children

Dosage (volume) of the substance in the preparation

1.5 mg, 1 mg

Expiration date in days

730

Package weight, g

ten

Mode of application

:

Locally.

It is used after eating, by absorption in the mouth, without chewing.

Immediately after using the drug, you should refrain from eating and drinking for 1-2 hours. < br> Dosage for children from 4 to 12 years old: 1 tablet 4 times a day.

The maximum daily dose is 4 tablets. < br> Dosage for children over 12 years of age and adults: 2 tablets (one after the other within 20-30 minutes) 4 times a day.

The maximum daily dose is 8 tablets.

In the absence of a therapeutic effect within 7 days of taking the drug, it is recommended to consult a doctor.